IPO registrations (S-1, F-1) · Registrants
Midatech Pharma US Inc.
- SEC CIK
- 919745 · filings on EDGAR ↗
- Name on the registration
- DARA BioSciences, Inc.
- Former names
- DARA BioSciences, Inc. (2008–2015); DARA BIOSCIENCES INC (2007–2008); POINT THERAPEUTICS INC (2002–2008); HMSR INC (2001–2002); HEMASURE INC (1996–2001)
- Registration
- Form S-1, first filed 2000-03-31, last 2014-05-22; 5 initial registrations, 14 amendments
- Outcome
- Final prospectus filed 2010-12-29; declared effective 2007-12-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 8601 SIX FORKS ROAD SUITE 160, Raleigh, NC 27615
- EIN
- 04-3216862
- EDGAR entity type
- operating
- Insiders and CEO pay
- Midatech Pharma US Inc. on the corporate pages
Offering terms
- Final price
- $2.50 per share (424B4 filed 2010-12-29)
- Shares sold
- 4,800
- Gross proceeds
- $12,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol DARA
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: DARA BIOSCIENCES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Federal award recipient: MIDATECH PHARMA US INC. Fuzzy (name and state)
- Form D issuer: DARA BioSciences, Inc. EXACT (CIK (EXACT))
- SEC filer: DARA BioSciences, Inc. EXACT (CIK (EXACT))
- Person page: Kurt M Eichler Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Richard N Small Cpa Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 54
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-03-31 | S-1 | S-1 (registration) | HEMASURE INC | 0000903112-00-000747 ↗ |
| 2000-05-31 | S-1/A | S-1/A (amendment) | HEMASURE INC | 0000903112-00-000905 ↗ |
| 2003-11-18 | S-1 | S-1 (registration) | POINT THERAPEUTICS INC | 0001193125-03-083427 ↗ |
| 2003-12-19 | S-1/A | S-1/A (amendment) | POINT THERAPEUTICS INC | 0001193125-03-097009 ↗ |
| 2007-12-26 | EFFECT | EFFECT (declared effective) | POINT THERAPEUTICS INC | 9999999995-07-005082 ↗ |
| 2008-04-18 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-08-001124 ↗ |
| 2010-04-02 | S-1 | S-1 (registration) | DARA BioSciences, Inc. | 0001193125-10-075962 ↗ |
| 2010-05-17 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001193125-10-120902 ↗ |
| 2010-09-16 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001193125-10-211462 ↗ |
| 2010-11-12 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001193125-10-259063 ↗ |
| 2010-12-27 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-10-003710 ↗ |
| 2010-12-29 | S-1MEF | S-1MEF (added securities) | DARA BioSciences, Inc. | 0001193125-10-289448 ↗ |
| 2010-12-29 | 424B4 | 424B4 (final prospectus) | DARA BioSciences, Inc. | 0001193125-10-289540 ↗ |
| 2011-04-19 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-11-001076 ↗ |
| 2012-02-23 | S-1 | S-1 (registration) | DARA BioSciences, Inc. | 0001193125-12-074169 ↗ |
| 2012-03-13 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001193125-12-112331 ↗ |
| 2012-03-26 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001193125-12-131531 ↗ |
| 2012-04-04 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001193125-12-149561 ↗ |
| 2012-04-06 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001193125-12-152403 ↗ |
| 2012-04-06 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-12-000965 ↗ |
| 2012-04-10 | 424B1 | 424B1 (final prospectus) | DARA BioSciences, Inc. | 0001193125-12-157296 ↗ |
| 2012-04-26 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-12-001186 ↗ |
| 2012-04-26 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-12-001189 ↗ |
| 2013-04-10 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-13-000947 ↗ |
| 2013-05-01 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-13-001288 ↗ |
| 2013-05-01 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-13-001310 ↗ |
| 2013-12-16 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-13-003571 ↗ |
| 2013-12-23 | S-1 | S-1 (registration) | DARA BioSciences, Inc. | 0001354488-13-006994 ↗ |
| 2014-02-26 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-14-000524 ↗ |
| 2014-02-26 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-14-000527 ↗ |
| 2014-03-20 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-14-000714 ↗ |
| 2014-04-18 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001354488-14-001972 ↗ |
| 2014-05-13 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001354488-14-002469 ↗ |
| 2014-05-14 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001354488-14-002566 ↗ |
| 2014-05-20 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001354488-14-002883 ↗ |
| 2014-05-22 | S-1/A | S-1/A (amendment) | DARA BioSciences, Inc. | 0001354488-14-002937 ↗ |
| 2014-05-29 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-14-001611 ↗ |
| 2014-06-02 | 424B4 | 424B4 (final prospectus) | DARA BioSciences, Inc. | 0001354488-14-003063 ↗ |
| 2015-04-06 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-15-000788 ↗ |
| 2015-04-06 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-15-000791 ↗ |
| 2015-04-06 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-15-000795 ↗ |
| 2015-04-07 | EFFECT | EFFECT (declared effective) | DARA BioSciences, Inc. | 9999999995-15-000813 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003260 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003261 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003263 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003265 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003266 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003267 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003269 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003271 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003272 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003273 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003274 ↗ |
| 2015-12-14 | EFFECT | EFFECT (declared effective) | Midatech Pharma US Inc. | 9999999995-15-003276 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2010-11-12 | S-1/A | registration statement | 4,000 | - | Nasdaq DARA | 0 | primary document; shares headline | document ↗ | ||
| 2010-12-29 | 424B4 | final prospectus | $2.50 | 4,800 | $12,000 | Nasdaq DARA | 0 | primary document; price line, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARBERICH TIMOTHY J | Director | 3 | 2006 | ||
| Benjamin Richard J | Director | 1 | 2006 | ||
| CLAFLIN THOMAS M II | Director | 1 | 2006 | ||
| Pickering Larry G | Director | 1 | 2006 | ||
| ROBLE DANIEL T | Director | 5 | 2006 | ||
| WHELAN WILLIAM J JR | Director | 3 | 2006 | ||
| UPRICHARD MARGARET J | Officer | SVP, Chief Development Officer | 2 | 2006 | |
| DUFFY MICHAEL P | Officer | SVP, GC and Secretary | 1 | 2006 | |
| JONES BARRY | Officer | Senior Vice President,Research | 1 | 2006 | |
| KIEPERT DONALD R JR | Director,Officer | Chairman, President, CEO | 1 | 2006 | |
| SMALL RICHARD N | Officer | SeniorVP,CFO,Treasurer | 1 | 2006 | person page Fuzzy |
| D'ALONZO THOMAS W | Director | 1 | 2008 | ||
| Didsbury John | Officer | Chief Scientific Officer; COO and Chief Scientic Officer | 3 | 2008 | |
| Eichler Kurt M | Director | 1 | 2008 | person page Fuzzy | |
| GORLIN STEVE | Director | 4 | 2008–2012 | ||
| JORDAN HAMILTON | Director | 1 | 2008 | ||
| McWhorter Stuart C | Director | 1 | 2008 | ||
| Thomas John C | Director; Officer | CFO and Secretary | 5 | 2008–2012 | |
| FRANCO RICHARD A | Director,Officer | CEO; Chairman, President and CEO; President & CEO | 16 | 2008–2011 | |
| COCHRANE HAYWOOD D | Director | 19 | 2008–2015 | ||
| Drutz David | Director; Director,Officer | CEO and CMO; Executive Chairman and CMO; President and CEO | 20 | 2008–2015 | |
| CAUWENBERGH GEERT | Director | 3 | 2008–2009 | ||
| Rosar Ann A | Officer | Chief Accounting Officer; Vice President Finance | 6 | 2009–2012 | |
| Lieberman Gail | Director | 15 | 2009–2015 | ||
| CLEMENT CHRISTOPHER G | Director,Officer | Chief Executive Officer; Chief Operating Officer; President; President and COO | 13 | 2012–2015 | |
| Tousley David L. | Officer | Acting Chief Financial Officer; CFO; Chief Financial Officer | 6 | 2012–2015 | |
| JAEGER STEPHEN O | Director | 4 | 2012–2013 | ||
| Heady Timothy James | Director | 11 | 2012–2015 | ||
| Richardson Paul John | Director | 8 | 2013–2015 | ||
| Benharris David | Officer | Senior Vice President | 2 | 2015 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2012-01-31 | DARA BioSciences, Inc. | Pharmaceuticals | Indefinite | $1,448,928 | 10 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | DARA BIOSCIENCES, INC. | NC | State business registries | EIN (EXACT, as the state registration reports it) |
| Federal award recipient | MIDATECH PHARMA US INC. | NC | Federal spending (USAspending) | name and state |
| Form D issuer | DARA BioSciences, Inc. | NC | Form D private offerings | CIK (EXACT) |
| SEC filer | Midatech Pharma US Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Midatech Pharma US Inc. | NC | Trademarks (USPTO) | name and state |
| Person page | Kurt M Eichler | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Richard N Small Cpa | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NC first:
- SALIX PHARMACEUTICALS LTD NC
- TRIANGLE PHARMACEUTICALS INC NC
- INSPIRE PHARMACEUTICALS INC NC
- POZEN INC /NC NC
- ARGOS THERAPEUTICS INC NC
- CHIMERIX INC NC
- ENDEAVOR PHARMACEUTICALS INC NC
- CORNERSTONE THERAPEUTICS INC NC
- Talecris Biotherapeutics Holdings Corp. NC
- Biolex Therapeutics, Inc. NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health